Starting the year with cardio-smart habits🫀
#hearthealthtalk#Cardiotwitter
🏃🏽♀️🚶🏽♀️150–300 min/week of moderate activity
(or 75–150 min vigorous) is associated with:
⬇️ All-cause mortality
⬇️ CV mortality
⬇️ MI & stroke risk
Exercise is not optional; it’s preventive cardiology.🩸
#cardiotwitter #exercise
The biggest cause of “resistant” hypertension isn’t what you think…👀🩺
#Cardiotwitter#hypertension
It’s not renal artery stenosis 🚫
Not CKD 🚫
Not pheochromocytoma 🚫
The #1 cause is poor medication adherence 💊❌.
Sepsis bundles matter. 🧠Treatment pillars consist of;
Fluids: 30 mL/kg IV crystalloid within 3 hrs 💧
Antibiotics: Broad-spectrum within 1 hr, tailored to risk factors & local resistance 💊
Source control: Drain abscess, remove infected lines, obtain blood cultures.
⏱️ Time is myocardium in MI, but in sepsis… time is life.
#SepsisAwarenessMonth #hearthealthtalk
Want to know some fun Atrial Fibrillation facts?👇🏾
🏃♂️ Endurance athletes = higher risk of A.fib (atrial stretch, vagal tone, fibrosis).
🍷 “Holiday Heart” - binge drinking can trigger AFib even in healthy hearts!
#AtrialFibrillationAwarenessMonth#Meded#Cardiotwitter
👩🏾⚕️“My blood pressure’s 130/75 today, so I’m good, right?”
Not so fast.
#hearthealthtalk 🫀
Hypertension is often a silent killer-doing damage long before symptoms appear.
✅ Myth #1: “I’m young, I can’t have high BP.”
💡You can definitely have hypertension in your 20s-40s, and early-onset hypertension predicts strokes, heart failure, and kidney disease.
🧠Early prevention is key.
✅ Myth #2: “No symptoms means no damage.”
💡Hypertension can silently cause heart (LVH), kidney (microalbuminuria), and eye damage.
✅ Myth #3: “One normal BP reading means I’m fine.”
💡Blood pressure varies; trends matter more than a single reading.
🧠Ambulatory or home monitoring helps track true BP.
🫀 Whether you’re managing hypertension clinically or living with it, track your numbers, know your targets, and protect your future.
#hearthealthtalk #meded #Cardiology #ACCintouch
#ResearchFridays
📚Is Finerenone (Kerendia) the new MRA hero for HFmrEF?
(FINEARTS-HF trial, NEJM 2024)
A non-steroidal mineralocorticoid receptor antagonist trusted in CKD/T2DM is now breaking ground in HFpEF/HFmrEF (EF ≥40%).
Let’s break down the trial that shook things up👇🏾
#CardioEd #Medtwitter #Researchfridays
🫀What are the key EKG changes in hyperkalemia?
Let’s talk about it
#hearthealthtalk
🩸Hyperkalamia is regarded as potassium levels above 5.5 mmol according to the AHA, and levels as high as 8mmol can cause sudden cardiac arrest